KBG Corp, formerly Korea Bio-Gen Co Ltd, is a Korea-based company mainly engaged in silicone materials business. The Company manufactures and sells silicone materials such as silane monomers, silicone resins and polymers, and silicone fusion materials. The Company also produces and sell fine chemicals and bio products.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
03/08/26	₩2,810.00	+2.37%	13,928
31/07/26	₩2,745.00	+2.43%	9,827
30/07/26	₩2,680.00	+3.28%	22,763
29/07/26	₩2,595.00	-9.90%	54,329
28/07/26	₩2,880.00	-1.54%	15,217

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. Other stock markets 03/08/2026			5-day change	1st Jan Change
2,810.00 ^KRW	+2.37%		-3.93%	-36.14%

11-05	KBG Corp. announces Annual dividend, payable on April 10, 2026	CI
10/07/24	KBG Corp. completed the acquisition of Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD.	CI

Market Cap	24.45B 17.08M 14.84M 13.85M 12.72M 23.98M 1.63B 24.4M 163M 63.98M 812M 64.14M 62.72M 2.68B	P/E 2024	10.8x	P/E 2025	14.8x
Enterprise Value	7.71B 5.38M 4.68M 4.37M 4.01M 7.56M 513M 7.69M 51.5M 20.17M 256M 20.22M 19.77M 844M	EV / Sales 2024	1.22x	EV / Sales 2025	0.9x
Free-Float	63.58%	Yield 2024 *	-	Yield 2025	-

11-05	KBG Corp. announces Annual dividend, payable on April 10, 2026	CI
10/07/24	KBG Corp. completed the acquisition of Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD.	CI
27/06/24	KBG Corp. agreed to acquire Aerogel Korea Co. Ltd from TKG Taekwang CO.,LTD for KRW 8.3 billion.	CI
12/05/23	KBG Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
11/05/21	Korea Bio-Gen Co.,Ltd announced that it has received KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor	CI
09/05/21	Korea Bio-Gen Co.,Ltd announced that it expects to receive KRW 5 billion in funding from Daegyeong Investment Co., Ltd. and another investor	CI
16/09/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
16/09/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
15/09/20	Korea Bio-Gen Co.,Ltd's Equity Buyback announced on March 17, 2020, has expired with 79,364 shares, representing 0.98% for KRW 318.89 million.	CI
17/06/20	Tranche Update on Korea Bio-Gen Co.,Ltd's Equity Buyback Plan announced on March 17, 2020.	CI
17/03/20	Korea Bio-Gen Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	CI
16/03/20	Korea Bio-Gen Co.,Ltd authorizes a Buyback Plan.	CI
30/07/19	Korea Bio-Gen Co.,Ltd has completed an IPO in the amount of KRW 10.707 billion.	CI

1 day	+2.37%
1 week	-3.93%
Current month	+2.37%
1 month	-8.17%
3 months	-38.51%
6 months	-37.56%
Current year	-36.14%

KBG Corp. Share Price

Stocks

A318000

KR7318000007

Specialty Chemicals

Valuation: KBG Corp.

Chart: KBG Corp.

Latest news : KBG Corp.

Quotes and Performance

Course Extremes

Managers and Directors: KBG Corp.

Other Specialty Chemicals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	2,545	2,875
1 month	2,545	3,145
Current year	2,545	4,830
1 year	2,545	6,160
3 years	2,545	14,340
5 years	2,545	21,150
10 years	2,545	21,150

Manager	Title	Age	Since
Sam-Yeol Pu CEO	Chief Executive Officer	40	23/03/2022
Tae-Kyun Boo SAM	Sales & Marketing	60	29/02/2020
Sang-Ho Do AUD	Comptroller/Controller/Auditor	67	-

Director	Title	Age	Since
Tae-Ung Pu CHM	Chairman	68	-
Sam-Yeol Pu BRD	Director/Board Member	40	23/03/2022
Kyung Choi BRD	Director/Board Member	68	24/03/2024

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KBG CORP.	+2.37%	-3.93%	-48.63%	-69.59%	17.08M
ECOLAB INC.	+0.65%	+2.97%	+7.06%	+53.96%	78.64B
GIVAUDAN SA	+1.02%	+1.40%	-4.34%	+14.45%	37.12B
SIKA AG	+2.97%	+16.12%	-2.78%	-30.18%	37.03B
FUJIFILM HOLDINGS CORPORATION	-0.34%	+0.29%	+21.76%	+41.86%	28.58B
EMS-CHEMIE HOLDING AG	+1.04%	+4.89%	+28.56%	+16.83%	23.81B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-0.04%	-2.56%	+87.23%	-4.67%	19.15B
DUPONT DE NEMOURS, INC.	+3.12%	+0.94%	-32.67%	-38.94%	19.08B
SYMRISE AG	+0.22%	+2.55%	+14.17%	-3.52%	14.05B
ALBEMARLE CORPORATION	+0.91%	+2.18%	+74.83%	-40.45%	14B
Average	+1.18%	+2.47%	+14.52%	-6.02%	27.15B
Weighted average by Cap.	+1.06%	+3.66%	+14.31%	+14.04%

	2024	2025
Net sales	24.92B 17.4M 15.13M 14.12M 12.96M 24.44M 1.66B 24.87M 167M 65.21M 827M 65.37M 63.92M 2.73B	23.92B 16.71M 14.52M 13.56M 12.45M 23.47M 1.59B 23.88M 160M 62.61M 794M 62.76M 61.37M 2.62B
Net income	3.77B 2.63M 2.29M 2.13M 1.96M 3.7M 251M 3.76M 25.17M 9.86M 125M 9.88M 9.66M 412M	2.59B 1.81M 1.57M 1.47M 1.35M 2.54M 173M 2.59M 17.32M 6.78M 86.05M 6.8M 6.65M 284M
Net Debt	-10.55B -7.37M -6.41M -5.98M -5.49M -10.35M -703M -10.54M -70.54M -27.63M -350M -27.69M -27.08M -1.16B	-16.74B -11.69M -10.16M -9.49M -8.71M -16.42M -1.11B -16.71M -112M -43.81M -556M -43.92M -42.95M -1.83B